Innoray
Latest round
- Series B
Last raised
- Jun 2025
Total raised
- $4.4M
Investors
- 3
About Innoray
, dba Innoray, specializes in manufacturing dual-energy bone densitometers for the Chinese healthcare sector. Innoray specializes in advanced dual-energy bone densitometers, including the INNO-E and INNO-S models, designed to support osteoporosis screening, diagnosis, and treatment in China. Their products and supporting software, like Zhi Duo Xing for trabecular bone scoring, are widely used by hospitals, community clinics, and government health programs to improve bone health across the population. The company generates revenue by direct sales of their medical equipment and related services to healthcare institutions.
Who invested in Innoray
3 investors across 1 round
See all investors in Innoray
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 24, 2025
Amount
$4.4M
Investors
Questions about Innoray
Who invested in Innoray?
Innoray has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Innoray raised?
Innoray has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Innoray last raise money?
Innoray's most recent round on record is a Series B, in Jun 2025.
What does Innoray do?
, dba Innoray, specializes in manufacturing dual-energy bone densitometers for the Chinese healthcare sector.
Where is Innoray headquartered?
Innoray is headquartered in Shanghai, China.
Which VCs invest in companies like Innoray?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Innoray's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Innoray? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.